The following table provides an overview of the latest patents of Array Biopharma, Inc. that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3702351Nov 22, 2023Formulation Comprising A Mek Inhibitor2
EP3400943Dec 2, 2020Compounds For Use In The Treatment Of Erbb2+ Brain Cancer2
EP3000810Jul 19, 2017N3 Alkylated Benzimidazole Derivative As Mek Inhibitor1